Cassava Sciences, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the SAVA Class Action Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate